Strategic distribution partnership with Thomy F.E., d.o.o.

Tampere, Finland, 15 October 2025—Marginum Ltd, a Finnish medical technology company specialising in fluorescence-based tissue monitoring systems, has signed an exclusive distribution agreement with Thomy F.E., d.o.o., one of Slovenia’s leading distributors of medical and surgical technologies. Through this strategic partnership, Thomy F.E. will distribute Marginum’s HIVEN® device in Slovenia, Croatia and Bosnia and Herzegovina, expanding access to the company’s groundbreaking aspirate tissue monitoring solution across Central and Southeastern European markets.
 
The HIVEN® device, developed by Marginum, is intended for tissue fluorescence detection during fluorescence-guided surgical operations for suspected high-grade gliomas in which 5-aminolevulinic acid (5-ALA) is used. The device detects fluorescence of flowing tissues within a transparent tube and provides auditory feedback of tissue fluorescence for neurosurgeons. Designed to support surgeons in achieving more precise tissue differentiation and improved surgical outcomes, HIVEN® embodies Marginum’s commitment to innovation, patient safety and clinical excellence.

Expanding access in Southeastern Europe

“We are delighted to collaborate with Thomy F.E., whose deep market knowledge, established relationships with healthcare professionals, and proven track record make them an ideal partner,” said Samu Lehtonen MD, CEO of Marginum. “Their commitment to quality and long-standing presence complements our European growth strategy and reinforces our mission to bring advanced surgical technologies to operating rooms worldwide.”

Founded in 1993 and headquartered in Trzin, Slovenia, Thomy F.E., d.o.o. has established itself as a trusted distributor and representative of leading international medical device manufacturers. With more than 30 years of experience, the company supplies innovative medical technologies to hospitals, clinics, and healthcare institutions throughout Slovenia, Croatia and Bosnia and Herzegovina. Thomy F.E.’s portfolio includes products in vascular surgery, interventional radiology and other specialised medical fields.

Commenting on the new collaboration, Mojca Goričan, General Manager of Thomy F.E., d.o.o., stated: “We are proud to partner with Marginum to introduce the HIVEN® device to our markets. The technology perfectly aligns with our mission to provide healthcare professionals with reliable and advanced tools that enhance surgical precision and patient care. We believe this collaboration will bring meaningful benefits to hospitals and patients across the region.”

The partnership between Marginum and Thomy F.E. reflects both companies’ shared commitment to empowering medical professionals through innovation, expertise, and collaboration. By combining Marginum’s EU MDR-certified HIVEN® device and novel aspirate tissue monitoring technology with Thomy F.E.’s extensive regional network and distribution capabilities, the collaboration is set to expand access to next-generation surgical solutions across Southeastern Europe.

Additional information:

Samu Lehtonen MD
CEO, Marginum Ltd
samu.lehtonen@marginum.com
+358 40 579 7890

Nuša Šuklje 
Product Sales Specialist, Thomy F.E., d.o.o.
Nusa.Suklje@thomy-fe.si 
+386 51 618 398
 
Marginum is a Finnish medical technology company founded in 2020 and a leading innovator in fluorescence-guided oncological surgery, developing optical tissue monitoring systems. The CE-marked HIVEN® by Marginum enables safe and efficient monitoring of tumour tissues during cancer surgery by seamlessly integrating into existing surgical workflows. Marginum’s vision is to enable surgeons worldwide to perform safer, more precise operations and ultimately improve patient survival and quality of life. www.marginum.com

Thomy F.E., d.o.o. is a leading Slovenian company in the distribution of advanced medical and surgical technologies, founded in 1993 and headquartered in Trzin, Slovenia. With more than 30 years of experience, Thomy F.E. is a trusted partner for hospitals, clinics and healthcare institutions across Slovenia, Croatia and Bosnia and Herzegovina. The company collaborates with globally recognised medical technology manufacturers to ensure access to high-quality, evidence-based solutions for healthcare professionals.